# ControlRad

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/controlrad

- Industry: Medical Devices & Equipment
- Headquarters: Peachtree Corners, US
- Website: www.controlrad.com
- Total disclosed funding: $15M
- Latest round: Series C (Sep 15, 2020)
- Investors on record: 2

## About

ControlRad, Inc. innovates radiation management solutions, enhancing safety and efficiency in medical imaging, primarily for healthcare institutions across North America and Europe.ControlRad, Inc. was founded in 2011 and is based in Peachtree Corners, US. The company specializes in providing radiation management technologies. It has successfully completed 6 funding deals, with its latest funding round being a Series B of USD 15.00 mn led by Questa Capital Management on September 15, 2020. The company is co-led by CEOs Guillaume Bailliard and Steven Nichtberger.ControlRad specializes in advanced radiation management solutions, primarily aimed at enhancing safety and efficiency in medical imaging. The company's flagship offerings include innovative technologies designed to reduce radiation exposure during diagnostic and therapeutic procedures. Key products focus on optimizing radiation doses based on specific clinical needs by integrating real-time feedback mechanisms into imaging systems, thereby creating a more effective workflow in hospitals and clinics. ControlRad’s solutions cater primarily to healthcare institutions, including hospitals and outpatient surgery centers, primarily located in North America and Europe, where demand for enhanced safety measures in medical imaging is growing.The revenue model for ControlRad revolves around B2B transactions with healthcare providers, engaging in direct sales of its radiation management systems and technologies. Clients typically enter into agreements involving the purchase of equipment, along with ongoing service and maintenance contracts ensuring optimal functionality and compliance with safety standards. Revenue is generated not only from equipment sales but also from service agreements, which may include training, support, and software updates tailored to client requirements.ControlRad plans to utilize its recent funding from the Series B round to support new product development initiatives and to expand its market reach. The company is designing advanced solutions aimed at reducing radiation exposure even further and anticipates launching these products in the next 12 to 18 months. Additionally, ControlRad is targeting expansion into new geographic regions beyond North America and Europe. This strategic growth initiative is expected to enhance their market presence and meet the increasing demand for advanced radiation management solutions in emerging markets.

## Funding rounds

- Series C, Sep 15, 2020 — Questa Capital
- Series B, Oct 2, 2019, $15M — Questa Capital, Rapha Capital Management

## Investors

- Questa Capital (https://capitalatlas.ai/funds/questa-capital) — Series B, Series C
- Rapha Capital Management (https://capitalatlas.ai/funds/rapha-capital-management) — Series B